Philly drug maker seeks approval in EU for gene therapy – Philly.com
|
Philly drug maker seeks approval in EU for gene therapy
Philly.com Philadelphia gene therapy company Spark Therapeutics has applied to the European Medicines Agency for approval to sell its treatment of rare inherited blindness in the European Union. The experimental therapy, Luxturna, or voretigene neparvovec, … |
